- Men and women
- Age: 18–70 years
- Diagnosis of narcolepsy*, hypersomnia* or sleep apnoea*, or difficulty falling asleep and staying asleep (insomnia).
*Diagnosis can also be established at our centre.

In chronic sleep disorders such as narcolepsy, hypersomnia, difficulty falling asleep or staying asleep (insomnia), and sleep apnoea, the balance between sleep, wakefulness and, potentially, breathing is disrupted. This can have a significant impact on daily life and quality of life. This research study is investigating a potential new medication for adults with one of these sleep disorders.
Common symptoms include:
Study objectives:
In this research study, we compare an experimental medication with a placebo in patients with narcolepsy or idiopathic hypersomnia, difficulty falling asleep and/or staying asleep (insomnia), or sleep apnoea. Rather than simply treating the symptoms, this research study focuses on the underlying cause of the condition.
*Diagnosis can also be established at our centre.
You will receive personalised guidance from our team of physicians and researchers throughout the study. You are encouraged to ask questions at any stage and will receive support at every step to ensure you feel informed and clinically well-supported.
By participating, you contribute to the clinical understanding of how individuals with sleep disorders respond to a potential therapeutic intervention. The data collected will support the further development of this treatment and may generate valuable evidence for future clinical care.